Andrew Mark Griffin

This inventor holds 37 USPTO granted patents and 39 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Ion Channel Modulators. Top assignees: Praxis Precision Medicines, Inc., Sage Therapeutics, Inc.. Active years: 2020-2026.

USPTO Granted Patents = 37 (Patent Applications = 39)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 16)

EPO Patents = 10 (Patent Applications = 21)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 136(Granted Patents)

Location History:

L'lle Bizard, CA (2020 - 2024)
L'Ile Bizard, CA (2021 - 2024)

Company Filing History:

23 out of 35

Praxis Precision Medicines, Inc.

patents

14 out of 99

Sage Therapeutics, Inc.

patents

Years Active: 2020-2026

Loading Chart...

Areas of Expertise:

KCNT1 Inhibitors

Oxysterols

Ion Channel Modulators

Neuroactive Steroids

Substituted Pyridines

Triazolo Compounds

Sodium Channel Activity

Compounds Methods

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655175 - C17, C20, and C21 substituted neuroactive steroids and their methods of use (2026-06-16),

2. 12655151 - Ion channel modulators (2026-06-16),

3. 12583849 - KCNT1 inhibitors and methods of use (2026-03-24),

4. 12552797 - Process for making (3-[cyclopropylethoxy(difluoro)methyl]-6-6[5-fluoro-6-(2,2,2-trifluoroethoxy-3-pyridyl]- [1,2,4]triazolo[4,3-a]pyrazine (2026-02-17),

5. 12540157 - Oxysterols and methods of use thereof (2026-02-03),

6. 12479844 - Ion channel modulators (2025-11-25),

7. 12344615 - Substituted pyridines as ion channel modulators (2025-07-01),

8. 12331070 - C7 substituted oxysterols and methods of use thereof (2025-06-17),

9. 12325711 - 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator (2025-06-10),

10. 12180247 - Oxysterols and methods of use thereof (2024-12-31),

11. 12145939 - Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators (2024-11-19),

12. 12030881 - Ion channel modulators (2024-07-09),

13. 11993628 - C7, C12, and C16 substituted neuroactive steroids and their methods of use (2024-05-28),

14. 11926646 - C7 substituted oxysterols and methods of use thereof (2024-03-12),

15. 11918571 - Compounds and their methods of use (2024-03-05),

Title: Andrew Mark Griffin - Inventor Extraordinaire

Introduction: Andrew Mark Griffin is a prolific inventor based in L'ile Bizard, Canada, known for his groundbreaking contributions to various industries.

Latest Patents: Andrew Mark Griffin's latest patents include innovative technologies in the fields of renewable energy, sustainable agriculture, and advanced robotics.

Career Highlights: Throughout his career, Andrew Mark Griffin has received numerous accolades for his inventive spirit and has been recognized for his patents that have significantly impacted the way we live and work.

Collaborations: Andrew Mark Griffin has collaborated with leading research institutions, universities, and companies worldwide to bring his inventions to life and make a positive difference in the world.

Conclusion: Andrew Mark Griffin's passion for innovation and his dedication to creating a better future through his inventions make him a true pioneer in the world of technology.